iBio Inc (IBIO): This will continue to be heavily manipul...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	22
Posts	1431
Boards Moderated	0
Alias Born	08/17/2009

Double-Down

Re: seriousonly post# 8451

Sunday, 10/26/2014 10:45:28 PM

Sunday, October 26, 2014 10:45:28 PM

This will continue to be heavily manipulated by the market in the current trading range until a deal breaks. Expect the next couple weeks to be a gut check for longs. Good luck.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IBIO News

Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 01:00:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 12:44:38 PM
iBio Amends and Extends Maturity of Credit Agreement • GlobeNewswire Inc. • 12/26/2023 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:17:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:13:08 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2023 01:59:51 PM
iBio, Inc. Announces Pricing of $4.5 Million Public Offering • GlobeNewswire Inc. • 12/05/2023 01:00:00 PM

More IBIO News

InvestorsHub NewsWire

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover